PRODROMAL SYMPTOMS AMONG MI PATIENTS
Not Applicable
- Conditions
- Health Condition 1: I00-I99- Diseases of the circulatory system
- Registration Number
- CTRI/2021/11/038262
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Both inpatients and outpatients of any age diagnosed with MI, who can communicate
verbally and had at least one PS during the past three months.
Exclusion Criteria
Patients who are diagnosed with serious conditions and who are unable to respond to
the questionnaires and psychiatric conditions.
Pregnant patients
Patients who are not willing to give consent.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The study could help to analyse the: <br/ ><br>� Most frequent prodromal symptoms associated with myocardial infarction. <br/ ><br>� Most frequent risk factors associated with the prodromal symptoms of myocardial <br/ ><br>infarction. <br/ ><br>� The association of prodromal symptoms among myocardial infarction patients with or <br/ ><br>without risk factors.Timepoint: Date of admission to date of discharge as well as day of outpatient consultations
- Secondary Outcome Measures
Name Time Method � The association of prodromal symptoms among myocardial infarction patients with or <br/ ><br>without risk factors.Timepoint: Date of admission to date of discharge as well as day of outpatient consultations
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie prodromal symptoms in myocardial infarction patients?
How do prodromal symptoms compare to standard-of-care diagnostic indicators for MI?
Which biomarkers are associated with prodromal symptoms in circulatory system diseases?
What adverse events are linked to prodromal symptoms in MI and how are they managed?
Are there related compounds or combination therapies that address prodromal symptoms in cardiovascular disease?